SPONSORED BY:

A Research Revolution

 

Email To A Friend

Please fill in the following information and we'll email this link.

Separate multiple addresses with commas

SPONSORED BY
 

Label

Newsweek Top Stories
Visions of a Decade
Visions of a Decade

From 2000-2009, one photo per month.

The Failure of Copenhagen
The Failure of Copenhagen

Why there could be a silver lining in a failed climate treaty.

Sex Scandals of the 2000s
Sex Scandals of the 2000s

From John Edwards to Mark Sanford, the decade's memorable affairs.

118 Days in Hell
118 Days in Hell

A NEWSWEEK journalist recounts his captivity in Iran.

Discuss

Sponsored by

Member Comments

  • Posted By: symmecon @ 11/04/2008 6:21:21 AM

    Comment: One way to look for a timely model for medical research on a molecular level would be to find the motion filed in U.S. District (NM) Court of 04/02/01, titled The Solution to the Equation of Schrodinger. It leads to the U.S. copyright TXu1-266-788, which presents the grand unified topological model of the atom as a picoyoctotechnical interactive point map for all particles, fields, and waves.

  • Posted By: angelface @ 12/22/2007 9:54:33 PM

    Learn more about investing by visiting investmentsforme.com

  • Posted By: jimbbb @ 12/14/2007 2:45:01 PM

    I suppose this topic has now gone cold. But for any latecomers (and definitely for Andy Grove himself) you can look at the new article by Paul Albert over on Bacteriality.com:

    http://bacteriality.com/2007/12/11/opensource/

    I think Paul has a very good point. The 'correct' model for the medical research community to use is not the Semiconductor Industry one, although that was a good first take on the subject -- it is the Open Source Software movement method that should be followed. Paul goes on to give an example of an Open Source Clinical trial as well to prove his point. (The point being that the trial is actually finding cures -- and quickly). If other clinical researchers (especially ones with deep pockets) could take the info and run with it for other illnesses (in parallel with the current ones being worked on) who knows how quickly a lot of them could be also put in the 'cure' bin? There is no reason right now that other researchers in say, MS, or ALS or Alzheimers fields could not also jump on this same bandwagon and attempt similar trials using the same protocol -- they just have not and will not give it a try -- it is hard to turn that giant medical establishment tanker in a new direction very quickly. Sad but true.

Reply

Report Abuse

Enter comments if any for reporting abuse

My Take

Customize the NEWSWEEK homepage
to feature your favorite columnists.

Customize Now